[1]丰婷,汪沅,聂欢,等.新型冠状病毒肺炎疫情下眼科门诊疾病谱分析及防疫处理对策[J].眼科新进展,2020,40(3):275-278.[doi:10.13389/j.cnki.rao.2020.0065]
 FENG Ting,WANG Yuan,NIE Huan,et al.Analysis and epidemic treatment measures of disease spectrum in ophthalmology clinic during novel coronavirus pneumonia (COVID-19) outbreaks[J].Recent Advances in Ophthalmology,2020,40(3):275-278.[doi:10.13389/j.cnki.rao.2020.0065]
点击复制

新型冠状病毒肺炎疫情下眼科门诊疾病谱分析及防疫处理对策/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年3期
页码:
275-278
栏目:
应用研究
出版日期:
2020-03-05

文章信息/Info

Title:
Analysis and epidemic treatment measures of disease spectrum in ophthalmology clinic during novel coronavirus pneumonia (COVID-19) outbreaks
作者:
丰婷汪沅聂欢彭建军
430080 湖北省武汉市,武汉科技大学附属普仁医院眼科(丰婷,彭建军);430080 湖北省武汉市,武汉科技大学附属普仁医院医务部(汪沅);430080 湖北省武汉市,武汉科技大学附属普仁医院急诊科(聂欢)
Author(s):
FENG Ting1WANG Yuan2NIE Huan3PENG Jianjun1
1.Department of Ophthalmology,Puren Hospital Affiliated to Wuhan University of Science and Technology,Wuhan 430080,Hubei Province,China2.Department of Medical Administration,Puren Hospital Affiliated to Wuhan University of Science and Technology,Wuhan 430080,Hubei Province,China3.
关键词:
新型冠状病毒肺炎眼科疾病谱
Keywords:
novel coronavirus pneumonia ophthalmology disease spectrum
分类号:
R771
DOI:
10.13389/j.cnki.rao.2020.0065
文献标志码:
A
摘要:
目的 探讨新型冠状病毒肺炎(COVID-19)疫情下眼科门诊疾病谱变化趋势及防疫处理对策。方法 采用整群抽样法,以2020年1月1日至2月9日眼科门诊患者为研究组,以2019年同期就诊患者为对照组。根据ICD-10标准对两组人群进行门诊疾病谱变化趋势分析。结果 2020年1月20日以前患者病例数及前十位病种分布及构成比较前无明显改变,但1月20日以后患者病例数明显减少,前十位病种分布及构成和就诊年龄改变明显。结论 疫情期间眼科仍有较多平诊患者,需加强宣教和咨询辅助工作以进一步减少人群流动,对来诊患者,采取针对性防治措施,切断传染途径,避免疾病传播。
Abstract:
Objective To investigate the change trend of disease spectrum and relevant treatment measures for ophthalmic outpatients under novel coronavirus pneumonia (COVID-19) outbreaks.Methods The cluster sampling method was adopted. Ophthalmic outpatients from January 1, 2020 to February 9, 2020 were taken as the study group, and those treated in the same period in 2019 as the control group. According to the ICD-10 standard, the change trend of outpatient disease spectrum in two groups was analyzed.Results The number of patients and the distribution and composition of the top 10 disease groups had no significant difference comparing with those before January 20, 2020, but the number of patients significantly decreased after Jan 20, 2020, and there are significant change in the distribution and composition of the top 10 disease groups and the age of outpatients.Conclusion There are still many non-emergency patients in ophthalmology during the epidemic period, so it is necessary to strengthen propaganda, education and counseling assistance to further reduce the crowd flow. Targeted prevention and treatment measures should be taken to cut off the infectious route and avoid the spread of disease.

参考文献/References:

[1] CHEN N,ZHOU M,DONG X,QU J,GONG F,HAN Y,et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,China: a descriptive study[J].Lancet,2020,395(10223):507-513.
[2] HUANG C,WANG Y,LI X,REN L,ZHAO J,HU Y,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].Lancet,2020,395(10223):497-506.
[3] 国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL].(2020-02-04)[ 2020-02-04].http://www.nhc.gov.cn/xcs/zhengcwj/202002/3b09b894ac9b4204a79 db5b8912d4440.shtml.
General Office of National Health Commission.Diagnosis and treatment of novel coronavirus pneumonia (5th trial edition)[EB/OL].(2020-02-04)[2020-02-04].http://www.nhc.gov.cn/xcs/zhengcwj/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
[4] 綦振滇.流行传染病的控制及预防方法探讨[J].世界最新医学信息文摘,2018,18(46):296.
QI Z D.Discussion on the methods of control and prevention of epidemic infectious diseases [J].World Lat Med Informat,2008,18(46):296.
[5] ZHU N,ZHANG D,WANG W,LI X,YANG B,SONG J,et al.A novel coronavirus from patients with pneumonia in China,2019 [J].N Engl J Med,2020,382(8):727-733.
[6] 张文福,何俊美,帖金凤,苏裕心,任哲.冠状病毒的抵抗力与消毒[J].中国消毒学杂志,2020,37(1):63-67.
ZHANG W F,HE J M,TIE J F,SU Y X,REN Z.Resistance and disinfection of coronavirus [J].Chin J Disinfect,2020,37 (1): 63-67.
[7] 孙琰,潘欣,柳林,倪灿荣.SARS-CoVS 蛋白功能性受体ACE2在人、兔角膜、结膜中的表达[J].眼科新进展,2004,24(5): 332-336.
SUN Y,PAN X,LIU L,NI C R.Expression of SARS coronavirus S protein functional receptor ACE2 in human and rabbit cornea and conjunctiva [J].Rec Adv Ophthalmol,2004,24(5): 332-336.
[8] LU C W,LIU X F,JIA Z F.2019-nCoV transmission through the ocular surface must not be ignored [J].Lancet,2020,395(10224):e39.
[9] WANG W,TANG J,WEI F.Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan,China[J].J Med Virol,2020,92(4):441-447.
[10] 丁伟,祝晓璐,王倩,柯敏.新型冠状病毒肺炎与眼的关系及防护建议[J].医学新知,2020,30(2):29-33.
DING W,ZHU X L,WANG Q,KE M.Relationship between novel coronavirus pneumonia (NCP) and eyes and relevant protctive suggestions[J].New Med,2020,30(2):29-33.
[11] 齐晔,陈刘欢,张栗,杨瑛莹,詹思怡,傅传喜.新型冠状病毒肺炎的公众认知、态度和行为研究[J].热带医学杂志,2020,20(2):1-12.
QI Y,CHEN L H,ZHANG L,YANG Y Y,ZHAN S Y,FU C X.Public practice,attitude and knowledge of coronavirus disease[J].J Trop Med,2020,20(2):1-12.
[12] 张明昌,谢华桃,许康康,曹阳.新型冠状病毒疫情期间眼科检查器具的消毒及医务人员的防护[J].中华眼科杂志,2020,56:E001-E001.
ZHANFG M C,XIE H T,XU K K,CAO Y.Disinfection of ophthalmic examination equipments and professional protection of medical workers during period of the 2019 novel coronavirus epidemic [J].Chin J Ophthalmol,2020,56:E001-E001.
[13] 赵家良.重视和加强眼科防治传染病的工作[J].中华眼科杂志,2003,39(8):449-450.
ZHAO J L.Respect and strengthen the prevention and treatment finfectious diseases in ophthalmology[J].Chin J Ophthalmol,2003,39(8):449-450.
[14] SIEGEL J D,RHINEHART E,JACKSON M,CHIARELLO L.2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings[J].Am J Infect Control,2007,35(10 Suppl 2):S65-64.

相似文献/References:

[1]周希彬 黄一飞.医用牛心包在眼科的应用进展[J].眼科新进展,2013,33(1):000.
[2]吴梦竹 樊莹.转甲状腺素蛋白与眼科疾病的研究进展[J].眼科新进展,2013,33(10):000.
[3]周姝,夏文涛,刘瑞珏,等. 微视野检查评定视觉功能的临床应用研究进展[J].眼科新进展,2015,35(3):293.[doi:10.13389/j.cnki.rao.2015.0079]
 ZHOU Shu,XIA Wen-Tao,LIU Rui-Jue,et al. Applications and advances in visual function measured by microperimetry[J].Recent Advances in Ophthalmology,2015,35(3):293.[doi:10.13389/j.cnki.rao.2015.0079]
[4]徐柒华,廖洪斐.3D打印及其在眼科中的应用前景[J].眼科新进展,2016,36(3):295.[doi:10.13389/j.cnki.rao.2016.0080]
 XU Qi-Hua,LIAO Hong-Fei.3D printing technology and its potential application in ophthalmology[J].Recent Advances in Ophthalmology,2016,36(3):295.[doi:10.13389/j.cnki.rao.2016.0080]
[5]向菁,康丽华,管怀进.LncRNA在眼科疾病发生发展中的作用机制研究进展[J].眼科新进展,2017,37(6):579.[doi:10.13389/j.cnki.rao.2017.0147]
 XIANG Jing,KANG Li-Hua,GUAN Huai-Jin.Research progress on mechanism of lncRNA in ophthalmology disease[J].Recent Advances in Ophthalmology,2017,37(3):579.[doi:10.13389/j.cnki.rao.2017.0147]
[6]纪艳丽,彭广华.单细胞转录组测序在眼科研究领域中的应用[J].眼科新进展,2018,38(1):084.[doi:10.13389/j.cnki.rao.2018.0019]
 JI Yan-Li,PENG Guang-Hua.Application of single-cell RNA-sequencing in ophthalmology[J].Recent Advances in Ophthalmology,2018,38(3):084.[doi:10.13389/j.cnki.rao.2018.0019]
[7]吴秋欣,王慧,刘冬梅,等.表没食子儿茶素没食子酸酯(EGCG)抗氧化作用在眼科研究中的应用[J].眼科新进展,2019,39(3):287.[doi:10.13389/j.cnki.rao.2019.0065]
 WU Qiu-Xin,WANG Hui,LIU Dong-Mei,et al.Research advance of the mechanism of epigallocatechingallate against oxidative damage in ophthalmology[J].Recent Advances in Ophthalmology,2019,39(3):287.[doi:10.13389/j.cnki.rao.2019.0065]
[8]张国明,田娅.阿柏西普在眼科疾病治疗中的应用[J].眼科新进展,2020,40(1):001.[doi:10.13389/j.cnki.rao.2020.0001]
 ZHANG Guoming,TIAN Ya.Advances in application of Aflibercept for treatment of ocular diseases[J].Recent Advances in Ophthalmology,2020,40(3):001.[doi:10.13389/j.cnki.rao.2020.0001]
[9]刘媛媛,郝晶,徐晶,等.新型冠状病毒肺炎防控时期眼外伤急救流程管理[J].眼科新进展,2020,40(4):385.[doi:10.13389/j.cnki.rao.2020.0089]
 LIU Yuanyuan,HAO Jing,XU Jing,et al.Emergence management on ocular trauma during COVID-19 epidemic situation[J].Recent Advances in Ophthalmology,2020,40(3):385.[doi:10.13389/j.cnki.rao.2020.0089]
[10]樊倩,王雁,段学欣,等.智能生物传感器在眼科学领域的应用研究进展[J].眼科新进展,2021,41(5):484.[doi:10.13389/j.cnki.rao.2021.0101]
 FAN Qian,WANG Yan,DUAN Xuexin,et al.Advances of intelligent biosensor in ophthalmology[J].Recent Advances in Ophthalmology,2021,41(3):484.[doi:10.13389/j.cnki.rao.2021.0101]

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2020-03-05